Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,129,058
-
Total 13F shares
-
565,168
-
Share change
-
-22,573
-
Total reported value
-
$1,447,584
-
Price per share
-
$2.56
-
Number of holders
-
16
-
Value change
-
+$1,052,753
-
Number of buys
-
14
-
Number of sells
-
3
Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q1 2020
As of 31 Mar 2020,
AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
565,168 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, Hudson Bay Capital Management LP, VANGUARD GROUP INC, JANE STREET GROUP, LLC, Advisor Group Holdings, Inc., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Advisory Services Network, LLC, and Traynor Capital Management, Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.